{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T01:00:26Z","timestamp":1784941226882,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:00Z","timestamp":1784937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Science and Technology Program of Luzhou City","award":["2025JYJ048"],"award-info":[{"award-number":["2025JYJ048"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["lzujbky-2024-ou19"],"award-info":[{"award-number":["lzujbky-2024-ou19"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82360029"],"award-info":[{"award-number":["82360029"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"DOI":"10.1007\/s12026-026-09804-z","type":"journal-article","created":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:58Z","timestamp":1784937658000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bone marrow SUVmax on 18F-FDG PET \/ CT reflects disease burden and immunosuppressive microenvironment in newly diagnosed multiple myeloma"],"prefix":"10.1007","volume":"74","author":[{"given":"Hao","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huitao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenting","family":"Tie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liansheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5983-677X","authenticated-orcid":false,"given":"Lijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,25]]},"reference":[{"key":"9804_CR1","doi-asserted-by":"publisher","first-page":"289458","DOI":"10.1155\/2013\/289458","volume":"2013","author":"A Oranger","year":"2013","unstructured":"Oranger A, Carbone C, Izzo M, Grano M. Cellular Mechanisms of Multiple Myeloma Bone Disease. Clin Dev Immunol. 2013;2013:289458.","journal-title":"Clin Dev Immunol"},{"key":"9804_CR2","doi-asserted-by":"publisher","first-page":"591342","DOI":"10.3389\/fonc.2020.591342","volume":"10","author":"S Wu","year":"2020","unstructured":"Wu S, Kuang H, Ke J, Pi M, Yang D-H. Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma. Front Oncol. 2020;10:591342.","journal-title":"Front Oncol"},{"key":"9804_CR3","doi-asserted-by":"publisher","first-page":"1141851","DOI":"10.3389\/fonc.2023.1141851","volume":"13","author":"PS Rana","year":"2023","unstructured":"Rana PS, Goparaju K, Driscoll JJ. Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma. Front Oncol. 2023;13:1141851.","journal-title":"Front Oncol"},{"key":"9804_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12032-025-02807-0","volume":"42","author":"H Sutanto","year":"2025","unstructured":"Sutanto H, Sandra DY, Safira A, Adytia GJ, Waitupu A, Romadhon PZ. Genetic, epigenetic, and molecular determinants of multiple myeloma and precursor plasma cell disorders: a pathophysiological overview. Med Oncol. 2025;42:234.","journal-title":"Med Oncol"},{"key":"9804_CR5","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1016\/j.ejca.2005.11.037","volume":"42","author":"BGM Durie","year":"2006","unstructured":"Durie BGM. The role of anatomic and functional staging in myeloma: description of Durie\/Salmon plus staging system. Eur J Cancer. 2006;42:1539\u201343.","journal-title":"Eur J Cancer"},{"key":"9804_CR6","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00256-010-1088-9","volume":"40","author":"S Sager","year":"2011","unstructured":"Sager S, Erg\u00fcl N, Ciftci H, Cetin G, G\u00fcner SI, Cermik TF. The value of FDG PET\/CT in the initial staging and bone marrow involvement of patients with multiple myeloma. Skeletal Radiol. 2011;40:843\u20137.","journal-title":"Skeletal Radiol"},{"key":"9804_CR7","doi-asserted-by":"publisher","first-page":"250","DOI":"10.4110\/in.2017.17.4.250","volume":"17","author":"K Batsukh","year":"2017","unstructured":"Batsukh K, Lee S-E, Min GJ, et al. Distinct Clinical Outcomes between Paramedullary and Extramedullary Lesions in Newly Diagnosed Multiple Myeloma. Immune Netw. 2017;17:250\u201360.","journal-title":"Immune Netw"},{"key":"9804_CR8","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1016\/S1470-2045(17)30189-4","volume":"18","author":"M Cavo","year":"2017","unstructured":"Cavo M, Terpos E, Nanni C, et al. Role of 18F-FDG PET\/CT in the diagnosis and management of multiple myeloma and other plasma cell disorders: a consensus statement by the International Myeloma Working Group. Lancet Oncol. 2017;18:e206\u201317.","journal-title":"Lancet Oncol"},{"key":"9804_CR9","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1200\/JCO.2017.72.2975","volume":"35","author":"P Moreau","year":"2017","unstructured":"Moreau P, Attal M, Caillot D, et al. Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM\/DFCI 2009 Trial: Results of the IMAJEM Study. J Clin Oncol. 2017;35:2911\u20138.","journal-title":"J Clin Oncol"},{"key":"9804_CR10","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.3324\/haematol.2017.177139","volume":"103","author":"FE Davies","year":"2018","unstructured":"Davies FE, Rosenthal A, Rasche L, et al. Treatment to suppression of focal lesions on positron emission tomography-computed tomography is a therapeutic goal in newly diagnosed multiple myeloma. Haematologica. 2018;103:1047\u201353.","journal-title":"Haematologica"},{"key":"9804_CR11","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1007\/s00259-017-3909-8","volume":"45","author":"C Nanni","year":"2018","unstructured":"Nanni C, Versari A, Chauvie S, et al. Interpretation criteria for FDG PET\/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe). Eur J Nucl Med Mol Imaging. 2018;45:712\u20139.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9804_CR12","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3324\/haematol.2012.066555","volume":"98","author":"S Waheed","year":"2013","unstructured":"Waheed S, Mitchell A, Usmani S, et al. Standard and novel imaging methods for multiple myeloma: correlates with prognostic laboratory variables including gene expression profiling data. Haematologica. 2013;98:71\u20138.","journal-title":"Haematologica"},{"key":"9804_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1600-0609.2010.01575.x","volume":"86","author":"BM Elliott","year":"2011","unstructured":"Elliott BM, Peti S, Osman K, et al. Combining FDG-PET\/CT with laboratory data yields superior results for prediction of relapse in multiple myeloma. Eur J Haematol. 2011;86:289\u201398.","journal-title":"Eur J Haematol"},{"key":"9804_CR14","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1097\/RLU.0000000000000773","volume":"40","author":"C Sachpekidis","year":"2015","unstructured":"Sachpekidis C, Mai EK, Goldschmidt H, et al. (18)F-FDG dynamic PET\/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate. Clin Nucl Med. 2015;40:e300\u2013307.","journal-title":"Clin Nucl Med"},{"key":"9804_CR15","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.annonc.2020.11.014","volume":"32","author":"MA Dimopoulos","year":"2021","unstructured":"Dimopoulos MA, Moreau P, Terpos E, et al. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up\u2020. Ann Oncol. 2021;32:309\u201322.","journal-title":"Ann Oncol"},{"issue":"Suppl 6","key":"9804_CR16","doi-asserted-by":"publisher","first-page":"vi133","DOI":"10.1093\/annonc\/mdt297","volume":"24","author":"P Moreau","year":"2013","unstructured":"Moreau P, San Miguel J, Ludwig H, et al. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(Suppl 6):vi133\u2013137.","journal-title":"Ann Oncol"},{"key":"9804_CR17","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1631\/jzus.B2200277","volume":"23","author":"X YUE","year":"2022","unstructured":"YUE X, HUANG L, YANG Y, et al. High levels of serum IL-10 indicate disease progression, extramedullary involvement, and poor prognosis in multiple myeloma. J Zhejiang Univ Sci B. 2022;23:968\u201374.","journal-title":"J Zhejiang Univ Sci B"},{"key":"9804_CR18","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1038\/s41375-019-0470-4","volume":"33","author":"AK Mishra","year":"2019","unstructured":"Mishra AK, Dingli D. Metformin inhibits IL-6 signaling by decreasing IL-6R expression on multiple myeloma cells. Leukemia. 2019;33:2695\u2013709.","journal-title":"Leukemia"},{"key":"9804_CR19","doi-asserted-by":"publisher","first-page":"3592","DOI":"10.1182\/bloodadvances.2021005327","volume":"5","author":"I Akhmetzyanova","year":"2021","unstructured":"Akhmetzyanova I, Aaron T, Galbo P, et al. Tissue-resident macrophages promote early dissemination of multiple myeloma via IL-6 and TNF\u03b1. Blood Adv. 2021;5:3592\u2013608.","journal-title":"Blood Adv"},{"key":"9804_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10238-014-0308-3","volume":"15","author":"F Dammacco","year":"2015","unstructured":"Dammacco F, Rubini G, Ferrari C, Vacca A, Racanelli V. 18F-FDG PET\/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders. Clin Exp Med. 2015;15:1\u201318.","journal-title":"Clin Exp Med"},{"key":"9804_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1007\/s00259-015-3200-9","volume":"43","author":"C Nanni","year":"2016","unstructured":"Nanni C, Zamagni E, Versari A, et al. Image interpretation criteria for FDG PET\/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe). Eur J Nucl Med Mol Imaging. 2016;43:414\u201321.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"9804_CR22","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.bbmt.2015.03.001","volume":"21","author":"F Patriarca","year":"2015","unstructured":"Patriarca F, Carobolante F, Zamagni E, et al. The role of positron emission tomography with 18F-fluorodeoxyglucose integrated with computed tomography in the evaluation of patients with multiple myeloma undergoing allogeneic stem cell transplantation. Biol Blood Marrow Transpl. 2015;21:1068\u201373.","journal-title":"Biol Blood Marrow Transpl"},{"key":"9804_CR23","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.21037\/qims-21-85","volume":"11","author":"Y Silva","year":"2021","unstructured":"Silva Y, Riedinger J-M, Chr\u00e9tien M-L, et al. Comparison between tumour metabolism derived from 18F-FDG PET\/CT and accurate cytogenetic stratification in newly diagnosed multiple myeloma patients. Quant Imaging Med Surg. 2021;11:4299\u2013309.","journal-title":"Quant Imaging Med Surg"},{"key":"9804_CR24","doi-asserted-by":"publisher","first-page":"100598","DOI":"10.1016\/j.ejro.2024.100598","volume":"13","author":"S Xu","year":"2024","unstructured":"Xu S, Jiao S, Guo H, Chen W, Yao S. IMPeTUs parameters correlate with clinical features in newly diagnosed multiple myeloma. Eur J Radiol Open. 2024;13:100598.","journal-title":"Eur J Radiol Open"},{"key":"9804_CR25","doi-asserted-by":"publisher","first-page":"106959","DOI":"10.1016\/j.crad.2025.106959","volume":"87","author":"J Bao","year":"2025","unstructured":"Bao J, Xiong M, Zheng M, Huang P, Lin X. Tumour and adipose tissue uptake on 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography\/computed tomography (PET\/CT) predict immunotherapy response in recurrent or metastatic nasopharyngeal carcinoma. Clin Radiol. 2025;87:106959.","journal-title":"Clin Radiol"},{"key":"9804_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.radonc.2022.04.009","volume":"171","author":"BM Lee","year":"2022","unstructured":"Lee BM, Lee CG. Significance of mid-radiotherapy 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in esophageal cancer. Radiother Oncol. 2022;171:114\u201320.","journal-title":"Radiother Oncol"},{"key":"9804_CR27","doi-asserted-by":"crossref","unstructured":"G\u00fczel F, Tuzcu \u015eA, Ta\u015fdemir B. Metabolic parameters in F-fluorodeoxyglucose positron emission tomography\/computed tomography for treatment response in colorectal carcinoma. Rev Assoc Med Bras (1992). 2025;71:e20241024.","DOI":"10.1590\/1806-9282.20241024"},{"key":"9804_CR28","doi-asserted-by":"publisher","first-page":"504","DOI":"10.3892\/ol.2025.15250","volume":"30","author":"M Iwata","year":"2025","unstructured":"Iwata M, Kurata Y, Hayano K, et al. Dynamic whole-body positron emission tomography\/computed tomography for predicting treatment response to chemoradiotherapy in patients with esophageal cancer. Oncol Lett. 2025;30:504.","journal-title":"Oncol Lett"},{"key":"9804_CR29","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s40364-024-00646-1","volume":"12","author":"H Zhang","year":"2024","unstructured":"Zhang H, Li S, Wang D, et al. Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment. Biomark Res. 2024;12:96.","journal-title":"Biomark Res"},{"key":"9804_CR30","doi-asserted-by":"publisher","first-page":"e2250258","DOI":"10.1002\/eji.202250258","volume":"53","author":"D Rao","year":"2023","unstructured":"Rao D, Stunnenberg JA, Lacroix R, et al. Acidity-mediated induction of FoxP3\u2009+\u2009regulatory T cells. Eur J Immunol. 2023;53:e2250258.","journal-title":"Eur J Immunol"},{"key":"9804_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/intimm\/dxad035","volume":"36","author":"M Kondo","year":"2024","unstructured":"Kondo M, Kumagai S, Nishikawa H. Metabolic advantages of regulatory T cells dictated by cancer cells. Int Immunol. 2024;36:75\u201386.","journal-title":"Int Immunol"},{"key":"9804_CR32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/cmi.2015.07","volume":"13","author":"Y Mao","year":"2016","unstructured":"Mao Y, Yin S, Zhang J, et al. A new effect of IL-4 on human \u03b3\u03b4 T cells: promoting regulatory V\u03b41 T cells via IL-10 production and inhibiting function of V\u03b42 T cells. Cell Mol Immunol. 2016;13:217\u201328.","journal-title":"Cell Mol Immunol"},{"key":"9804_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/bs.ircmb.2024.08.003","volume":"391","author":"Q Fernandes","year":"2025","unstructured":"Fernandes Q, Ansari AW, Makni-Maalej K, et al. Interleukin 10: Bridging the chasms in the immune landscape of multiple myeloma. Int Rev Cell Mol Biol. 2025;391:199\u2013222.","journal-title":"Int Rev Cell Mol Biol"},{"key":"9804_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40164-024-00576-6","volume":"13","author":"J Pu","year":"2024","unstructured":"Pu J, Liu T, Sharma A, et al. Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma. Exp Hematol Oncol. 2024;13:105.","journal-title":"Exp Hematol Oncol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09804-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09804-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09804-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T00:00:59Z","timestamp":1784937659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09804-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9804"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09804-z","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"assertion":[{"value":"15 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Ethical Committee of Lanzhou University Second Hospital according to the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"75"}}